Business Wire

6-Year Data Published in Journal of Glaucoma Demonstrates Effective, Sustained Reduction in Intraocular Pressure with iTrack™ Canaloplasty

FREMONT, Calif.--(BUSINESS WIRE)--Nova Eye Medical Limited, a medical technology company committed to advanced ophthalmic treatment technologies and devices, is pleased to announce the peer review ...
Seeking Alpha

Nova Eye Medical Limited (ELXMF) Discusses Clinical Insights and Practice Advantages of iTrack Advance Glaucoma Device Prepared Remarks Transcript

Good morning, everyone, and thank you for joining us at Nova Eye. We're here to walk you through the clinical use of the iTrack Advance and share some direct insights from the field. With us today is, ...
The Globe and Mail

Nova Eye Medical Announces U.S. Market Clearance of the iTrack™ Advance Canaloplasty Device

Nova Eye Medical Limited (ASX: EYE) (Nova Eye Medical or the Company), a medical technology company committed to advanced ophthalmic treatment technologies and devices, today announces that it has ...
The Australian

Nova Eye Medical secures FDA clearance for iTrack Advance to treat glaucoma

Nova Eye Medical is celebrating after being given US FDA clearance for its updated surgical device to treat glaucoma, which is forecast to significantly expand its market in the US. The US Food and ...